Tuberculosis. In the initial treatment and in re-treatment of patients with tuberculosis, RIFADIN must be used in conjunction with at least one other antituberculosis drug. Leprosy. In the management of lepromatous leprosy and dimorphous leprosy to effect speedy conversion of the infectious state to the noninfectious state, which may be expected to occur in 3 to 4 months of treatment. As an alterantive drug in lepromatous, dimorphous, indeterminate and tuberculoid leprosy resistant to sulfones and other antileprosy drugs. As an alternative drug in all those patients having true drug allergy to the more commonly used antileprosy drugs. Meningococcal disease. Prophylaxis of meningococcal disease in close contacts of known cases and in carriers. (RIFADIN is not indicated for the treatment of meningococcal infections). Haemophilus influenzae. Prophylaxis of household contacts of patients with H. influenzae type B.
How to take it
This medicine is a pack that contains more than one part.
Part 1: Injection, powder for
Powder, red
The way to take this medicine is: Intravenous.
This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
Part 2: Diluent, not applicable
Clear liquid
The way to take this medicine is: Intravenous.
This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Storage instructions
Store below 25 degrees Celsius
Shelf lifetime is 3 Years.
Do I need a prescription?
These medicine packs are available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
1 vial of powder - 600mg pack
We are unable to tell you if you need a prescription for these medicines. You can ask your pharmacist. This medicine is
Not Scheduled.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Tuberculosis. In the initial treatment and in re-treatment of patients with tuberculosis, RIFADIN must be used in conjunction with at least one other antituberculosis drug. Leprosy. In the management of lepromatous leprosy and dimorphous leprosy to effect speedy conversion of the infectious state to the noninfectious state, which may be expected to occur in 3 to 4 months of treatment. As an alterantive drug in lepromatous, dimorphous, indeterminate and tuberculoid leprosy resistant to sulfones and other antileprosy drugs. As an alternative drug in all those patients having true drug allergy to the more commonly used antileprosy drugs. Meningococcal disease. Prophylaxis of meningococcal disease in close contacts of known cases and in carriers. (RIFADIN is not indicated for the treatment of meningococcal infections). Haemophilus influenzae. Prophylaxis of household contacts of patients with H. influenzae type B.
How to take it
The way to take this medicine is: Oral.
This medicine is taken by mouth.
Store below 25 degrees Celsius
Shelf lifetime is 3 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
Blue cap, red body capsules each marked "R-150" containing a brick-red coloured powder
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Tuberculosis. In the initial treatment and in re-treatment of patients with tuberculosis, RIFADIN must be used in conjunction with at least one other antituberculosis drug. Leprosy. In the management of lepromatous leprosy and dimorphous leprosy to effect speedy conversion of the infectious state to the noninfectious state, which may be expected to occur in 3 to 4 months of treatment. As an alterantive drug in lepromatous, dimorphous, indeterminate and tuberculoid leprosy resistant to sulfones and other antileprosy drugs. As an alternative drug in all those patients having true drug allergy to the more commonly used antileprosy drugs. Meningococcal disease. Prophylaxis of meningococcal disease in close contacts of known cases and in carriers. (RIFADIN is not indicated for the treatment of meningococcal infections). Haemophilus influenzae. Prophylaxis of household contacts of patients with H. influenzae type B.
How to take it
The way to take this medicine is: Oral.
This medicine is taken by mouth.
Store below 25 degrees Celsius
Shelf lifetime is 3 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
Dark red, homogenous suspension
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
Is this medicine subsidised?
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on April 1, 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Tuberculosis. In the initial treatment and in re-treatment of patients with tuberculosis, RIFADIN must be used in conjunction with at least one other antituberculosis drug. Leprosy. In the management of lepromatous leprosy and dimorphous leprosy to effect speedy conversion of the infectious state to the noninfectious state, which may be expected to occur in 3 to 4 months of treatment. As an alterantive drug in lepromatous, dimorphous, indeterminate and tuberculoid leprosy resistant to sulfones and other antileprosy drugs. As an alternative drug in all those patients having true drug allergy to the more commonly used antileprosy drugs. Meningococcal disease. Prophylaxis of meningococcal disease in close contacts of known cases and in carriers. (RIFADIN is not indicated for the treatment of meningococcal infections). Haemophilus influenzae. Prophylaxis of household contacts of patients with H. influenzae type B.
How to take it
The way to take this medicine is: Oral.
This medicine is taken by mouth.
Store below 25 degrees Celsius
Shelf lifetime is 3 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
Red, opaque capsules containing a red-brick coloured powder. Body and cap marked "R-300"
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Government Accredited with over 140 information partners
We are a government-funded service, providing quality, approved health information and advice
Healthdirect Australia acknowledges the Traditional Owners of Country throughout Australia and their continuing
connection to land, sea and community. We pay our respects to the Traditional Owners and to Elders both past and
present.